Down-regulation of SREBP-1c is associated with the development of burned-out NASH

Journal of Hepatology

Volumn 53, Issue 4, 2010, Pages 724-731

  Nagaya, Tadanobu ^a   Tanaka, Naoki ^a,b   Suzuki, Takefumi ^c   Sano, Kenji ^c   Horiuchi, Akira ^d   Komatsu, Michiharu ^a   Nakajima, Takero ^b   Nishizawa, Tomoko ^b   Joshita, Satoru ^a   Umemura, Takeji ^a   Ichijo, Tetsuya ^a   Matsumoto, Akihiro ^a   Yoshizawa, Kaname ^a   Nakayama, Jun ^b   Tanaka, Eiji ^a   Aoyama, Toshifumi ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

^d Neurosurgical Service (SIGNS)   (Japan)

Author keywords

Burned out NASH; SREBP 1c; TNF

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID; FATTY ACID SYNTHASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE CONTROL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOBLOTTING; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN SYNTHESIS; LIVER; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEATOSIS;

ADULT; CASE-CONTROL STUDIES; DOWN-REGULATION; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 77956268548     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.04.033     Document Type: Article

References (38)

1. N.M. de Alwis, and C.P. Day Non-alcoholic fatty liver disease: the mist gradually clears J Hepatol 48 2008 S104 S112
2. Y. Falck-Ytter, Z.M. Younossi, G. Marchesini, and A.J. McCullough Clinical features and natural history of nonalcoholic steatosis syndromes Semin Liver Dis 21 2001 17 26
3. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
4. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
5. T. Nagaya, N. Tanaka, M. Komatsu, T. Ichijo, K. Sano, and A. Horiuchi Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case Clin J Gastroenterol 1 2008 116 121
6. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152
7. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and L.W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
8. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, and C.J. Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
9. N. Tanaka, E. Tanaka, Y. Sheena, M. Komatsu, W. Okiyama, and N. Misawa Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population Liver Int 26 2006 956 963
10. M. Komatsu, M. Yazaki, N. Tanaka, K. Sano, E. Hashimoto, and Y. Takei Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease J Hepatol 49 2008 810 820
11. N. Tanaka, T. Nagaya, M. Komatsu, A. Horiuchi, G. Tsuruta, and H. Shirakawa Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase Liver Int 28 2008 1104 1111
12. N. Tanaka, T. Ichijo, W. Okiyama, H. Mutou, N. Misawa, and A. Matsumoto Laparoscopic findings in patients with nonalcoholic steatohepatitis Liver Int 26 2006 32 38
13. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
14. S. McPherson, J.R. Jonsson, H.D. Barrie, P. O'Rourke, A.D. Clouston, and E.E. Powell Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis J Hepatol 49 2008 1046 1054
15. X. Hua, J. Wu, J.L. Goldstein, M.S. Brown, and H.H. Hobbs Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13 Genomics 25 1995 667 673
16. I. Shimomura, H. Shimano, J.D. Horton, J.L. Goldstein, and M.S. Brown Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells J Clin Invest 99 1997 838 845
17. -ΔΔCT method Methods 25 2001 402 408
18. T. Aoyama, S. Yamano, D.J. Waxman, D.P. Lapenson, U.A. Meyer, and V. Fischer Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. CDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine J Biol Chem 264 1989 10388 10395
19. T. Aoyama, M. Souri, S. Ushikubo, T. Kamijo, S. Yamaguchi, and R.I. Kelley Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients J Clin Invest 95 1995 2465 2473
20. P. Ferré, and F. Foufelle SREBP-1c transcription factor and lipid homeostasis: clinical perspective Horm Res 68 2007 72 82
21. N. Tanaka, K. Hora, H. Makishima, Y. Kamijo, K. Kiyosawa, and F.J. Gonzalez In vivo stabilization of nuclear retinoid X receptor α in the presence of peroxisome proliferator-activated receptor α FEBS Lett 543 2003 120 124
22. T. Aoyama, J.M. Peters, N. Iritani, T. Nakajima, K. Furihata, and T. Hashimoto Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) J Biol Chem 273 1998 5678 5684
23. S. Mandard, M. Müller, and S. Kersten Peroxisome proliferator-activated receptor α target genes Cell Mol Life Sci 61 2004 393 416
24. M. Rakhshandehroo, G. Hooiveld, M. Müller, and S. Kersten Comparative analysis of gene regulation by the transcription factor PPARα between mouse and human PLoS One 4 2009 e6796
25. T. Nakajima, N. Tanaka, H. Kanbe, A. Hara, Y. Kamijo, and X. Zhang Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor α-independent mechanism Mol Pharmacol 75 2009 782 792
26. E.L. Abbot, J.G. McCornack, C. Reynet, D.G. Hassall, K.W. Buchan, and S.J. Yeaman Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells FEBS J 272 2005 3004 3014
27. H. Staiger, C. Haas, J. Machann, R. Werner, M. Weisser, and F. Schick Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-δ and is of metabolic relevance in humans Diabetes 58 2009 579 589
28. S. Yu, K. Matsusue, P. Kashireddy, W.Q. Cao, V. Yeldandi, and A.V. Yeldandi Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression J Biol Chem 278 2003 498 505
29. K. Matsusue, T. Kusakabe, T. Noguchi, S. Takiguchi, T. Suzuki, and S. Yamano Hepatic steatosis in leptin-deficient mice is promoted by the PPARγ target gene Fsp27 Cell Metab 7 2008 302 311
30. M.S. Kim, T.R. Sweeney, J.K. Shigenaga, L.G. Chui, A. Moser, and C. Grunfeld Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cells Metabolism 56 2007 267 279
31. I. Shimomura, Y. Bashmakov, and J.D. Horton Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus J Biol Chem 274 1999 30028 30032
32. ob mice J Biol Chem 277 2002 19353 19357
33. N. Higuchi, M. Kato, Y. Shundo, H. Tajiri, M. Tanaka, and N. Yamashita Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease Hepatol Res 38 2008 1122 1129
34. C. Mascaró, E. Acosta, J.A. Ortiz, P.F. Marrero, F.G. Hegardt, and D. Haro Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor J Biol Chem 273 1998 8560 8563
35. K.A. Burns, and J.P. Vanden Heuvel Modulation of PPAR activity via phosphorylation Biochim Biophys Acta 1771 2007 952 960
36. N. Tanaka, K. Moriya, K. Kiyosawa, K. Koike, and T. Aoyama Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor α in transgenic mice: implications for HCV-associated hepatocarcinogenesis Int J Cancer 122 2008 124 131
37. N. Tanaka, K. Moriya, K. Kiyosawa, K. Koike, F.J. Gonzalez, and T. Aoyama PPARα activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice J Clin Invest 118 2008 683 694
38. W. Okiyama, N. Tanaka, T. Nakajima, E. Tanaka, K. Kiyosawa, and F.J. Gonzalez Polyenephosphatidylcholine prevents alcoholic liver disease in PPARα-null mice through attenuation of increases in oxidative stress J Hepatol 50 2009 1236 1246